Moreover, by analyzing the distinct expression patterns and prognostic values of IGFBP family members in patients with NSCLC with bioinformatics tools, IGFBP-6 was downregulated in tumor samples as a result [88]. This evidence concerns the gene IGFBP6 and non-small cell lung carcinoma.